drugset / Trial / NCT01957189

This Will be an Open-label, Three-period, Fixed-sequence Study to Evaluate the Drug-drug Interaction, Pharmacokinetics and Safety of Dutasteride and Tamsulosin When Administered Alone and In-combination in Chinese Healthy Male Volunteers. The Study Will Last Approximately Eleven Weeks. Blood Samples

NCT01957189

Phase 1 Completed 24 enrolled GlaxoSmithKline
NaSingle-groupOpen-labelTreatment

Summary

This will be an open-label, three-period, fixed-sequence study to evaluate the drug-drug interaction, pharmacokinetics and safety of dutasteride and tamsulosin when administered alone and in-combination in Chinese healthy male volunteers.

Timeline

Start
2013-10-25
Primary completion
2014-01-22
Completion
2014-01-22

Drugs

EvaluationDrugModalityDoseRoute
Subject Dutasteride Small molecule 0.5 mg
Subject Tamsulosin Other / unclassified 0.2 mg